These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2690730

  • 1. Long-term efficacy of controlled-release carbidopa/levodopa in patients with advanced Parkinson's disease.
    Mark MH, Sage JI.
    Ann Clin Lab Sci; 1989; 19(6):415-21. PubMed ID: 2690730
    [Abstract] [Full Text] [Related]

  • 2. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease.
    Mark MH, Sage JI.
    Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations.
    Jankovic J, Schwartz K, Vander Linden C.
    Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215
    [Abstract] [Full Text] [Related]

  • 4. Trial of Sinemet CR4 in patients with Parkinson's disease.
    Anderson TJ, Ewer TC, Gilchrist NL, Donaldson IM.
    N Z Med J; 1992 Mar 11; 105(929):81-2. PubMed ID: 1545941
    [Abstract] [Full Text] [Related]

  • 5. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
    Hutton JT, Morris JL.
    Neurology; 1992 Jan 11; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202
    [Abstract] [Full Text] [Related]

  • 6. Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
    Hutton JT, Morris JL, Bush DF, Smith ME, Liss CL, Reines S.
    Neurology; 1989 Nov 11; 39(11 Suppl 2):67-72; discussion 72-3. PubMed ID: 2685652
    [Abstract] [Full Text] [Related]

  • 7. Controlled-release levodopa/carbidopa. III: Sinemet CR5 treatment of response fluctuations in Parkinson's disease.
    Cedarbaum JM, Hoey M, Kutt H, McDowell FH.
    Clin Neuropharmacol; 1988 Apr 11; 11(2):168-73. PubMed ID: 3378225
    [Abstract] [Full Text] [Related]

  • 8. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease.
    Feldman RG, Mosbach PA, Kelly MR, Thomas CA, Saint Hilaire MH.
    Neurology; 1989 Nov 11; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655
    [Abstract] [Full Text] [Related]

  • 9. Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.
    LeWitt PA, Nelson MV, Berchou RC, Galloway MP, Kesaree N, Kareti D, Schlick P.
    Neurology; 1989 Nov 11; 39(11 Suppl 2):45-53; discussion 59. PubMed ID: 2685650
    [Abstract] [Full Text] [Related]

  • 10. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A.
    Clin Neuropharmacol; 2009 Nov 11; 32(4):189-92. PubMed ID: 19620848
    [Abstract] [Full Text] [Related]

  • 11. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 11; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 12. The Sydney multicentre study of Parkinson's disease. The first 18 months.
    Hely MA, Morris JG, Rail D, O'Sullivan DJ, Williamson PM, Genge S, Reid WG, Broe GA.
    Med J Aust; 1987 Feb 16; 146(4):195-8. PubMed ID: 3553878
    [Abstract] [Full Text] [Related]

  • 13. Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
    Rodnitzky RL, Dickins QS, Dobson J.
    Neurology; 1989 Nov 16; 39(11 Suppl 2):92-5; discussion 95. PubMed ID: 2586769
    [Abstract] [Full Text] [Related]

  • 14. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
    Goetz CG, Tanner CM, Gilley DW, Klawans HL.
    Neurology; 1989 Nov 16; 39(11 Suppl 2):63-6; discussion 72-3. PubMed ID: 2586764
    [Abstract] [Full Text] [Related]

  • 15. Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
    Pahwa R, Lyons K, McGuire D, Silverstein P, Zwiebel F, Robischon M, Koller WC.
    Mov Disord; 1997 Sep 16; 12(5):677-81. PubMed ID: 9380047
    [Abstract] [Full Text] [Related]

  • 16. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa.
    Aarli JA, Gilhus NE.
    Neurology; 1989 Nov 16; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767
    [Abstract] [Full Text] [Related]

  • 17. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Hauser RA, Holford NH.
    Mov Disord; 2002 Sep 16; 17(5):961-8. PubMed ID: 12360545
    [Abstract] [Full Text] [Related]

  • 18. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
    García de Yébenes J, Mateo D, Pino MA, Cordero M, Pastor M, Chacón J, Morales B, Sánchez V, Mena MA, Giménez Roldán S.
    Neurologia; 1997 Apr 16; 12(4):145-56. PubMed ID: 9235023
    [Abstract] [Full Text] [Related]

  • 19. Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease.
    Lieberman A, Gopinathan G, Miller E, Neophytides A, Baumann G, Chin L.
    Eur Neurol; 1990 Apr 16; 30(2):75-8. PubMed ID: 2340838
    [Abstract] [Full Text] [Related]

  • 20. Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
    Rondot P, Ziegler M, Aymard N, Teinturier A.
    Neurology; 1989 Nov 16; 39(11 Suppl 2):74-7; discussion 95. PubMed ID: 2586765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.